NEU On Other Exchanges
text size: T | T
Back to Snapshot
Company Description

Contact Info

697 Burke Road

Suite 501

Camberwell, VIC 3124


Phone: 61 3 9092 0480


Neuren Pharmaceuticals Limited, a biopharmaceutical company, focuses on the development of therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its lead product is Trofinetide, which is in Phase II clinical trials for use in the treatment of Rett syndrome, Fragile X syndrome, moderate to severe traumatic brain injury, and concussion. The company is also developing NNZ-2591, a synthetic analogue of a naturally occurring neuropeptide that is in preclinical development for the treatment of various neurodegenerative disorders. Neuren Pharmaceuticals Limited is based in Camberwell, Australia.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

NEU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NEU.
View Industry Companies

Industry Analysis


Industry Average

Valuation NEU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 394.2x
Price/Book 11.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 349.4x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NEUREN PHARMACEUTICALS LTD, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at